BALANX LLC develops human-centered AI software and related wellbeing products. This website presents our work under the BalanX Bio brand, including Sandera conversational software and Genethra wellness and digital-twin research.
Company details
Registered entity
BALANX LLC
Website brand
BalanX Bio
Legal formation
Michigan, United States
Cofounders
Abe Shukeir Douglas Li
What we are building
Our software is built and in testing. Sandera’s beta is almost ready, and we are polishing it now. Access is arranged by request; physical products remain experimental.
Sandera
Software · Testing and beta preparation
Sandera focuses on conversational character interaction, contextual responses, and expressive digital companions. Its development explores how people interact with AI through conversation and character-based experiences.
The subscription page previews Sandera’s commercial model and capabilities. Beta access is arranged by request. Contact us for a demonstration and to confirm the features available to evaluate.
Genethra explores wellness-signal workflows and digital-twin research: ways to organize wellbeing information and investigate personalized digital representations.
Its product page distinguishes the current foundation from future capabilities that depend on further development and validation. Related physical products are experimental. These descriptions do not establish clinical efficacy or validated health outcomes.
BalanX began in 2025 and builds its own software products. Sandera’s published subscription model is the commercial foundation for its conversational software. Genethra remains a research and development direction for related wellbeing products.
Alongside our own software, we offer scoped biological-AI assessments, research strategy and pilot planning for organizations. Sandera access is coordinated by request during testing and beta preparation. Contact the team to discuss the current software, a demonstration and the capabilities available to evaluate.
Near-term roadmap
Beta testing and polish. Finish polishing Sandera and testing its core software experience.
Demonstrations and beta access. Arrange product demonstrations and requested access, with the available capabilities identified for the review version.
Commercial rollout. Use beta feedback to confirm supported features, platform availability and rollout timing.
These are the next milestones for Sandera. Genethra’s longer-term capabilities follow its separate research roadmap.
Connect with BalanX Bio
Connect with BalanX Bio to explore our technology, request beta access or a demonstration, and discuss partnership opportunities. Our team will help identify the right next step for your organization.